PTEN acts as a crucial inflammatory checkpoint controlling TLR9/IL-6 axis in B cells

Pei-Ju Tsai,Ming-Yu Chen,Wei-Chan Hsu,Su-Fang Lin,Po-Chiang Chan,Hsin-Hsin Chen,Cheng-Yuan Kao,Wen-Jye Lin,Tsung-Hsien Chuang,Guann-Yi Yu,Yu-Wen Su
DOI: https://doi.org/10.1016/j.isci.2024.110388
IF: 5.8
2024-06-26
iScience
Abstract:Phosphatase and tensin homolog (PTEN) is vital for B cell development, acting as a key negative regulator in the PI3K signaling pathway. We used CD23-cre to generate PTEN-conditional knockout mice (CD23-cKO) to examine the impact of PTEN mutation on peripheral B cells. Unlike mb1-cre-mediated PTEN deletion in early B cells, CD23-cKO mutants exhibited systemic inflammation with increased IL-6 production in mature B cells upon CpG stimulation. Inflammatory B cells in CD23-cKO mice showed elevated phosphatidylinositol 3-phosphate [PI(3)P] levels and increased TLR9 endosomal localization. Pharmacological inhibition of PI(3)P synthesis markedly reduced TLR9-mediated IL-6. Single-cell RNA-sequencing (RNA-seq) revealed altered endocytosis, BANK1, and NF-κB1 expression in PTEN-deficient B cells. Ectopic B cell receptor (BCR) expression on non-inflammatory mb1-cKO B cells restored BANK1 and NF-κB1 expression, enhancing TLR9-mediated IL-6 production. Our study highlights PTEN as a crucial inflammatory checkpoint, regulating TLR9/IL-6 axis by fine-tuning PI(3)P homeostasis. Additionally, BCR downregulation prevents the differentiation of inflammatory B cells in PTEN deficiency.
What problem does this paper attempt to address?